1. A pharmaceutical dosage form, comprising delayed-release cysteamine beads, the beads comprising:
(i) a core particle comprising cysteamine or a pharmaceutically acceptable salt thereof and a binder, and
(ii) an enteric membrane surrounding the core particle,
wherein the beads have a distribution of particle sizes in a range of about 0.7 mm to about 2.8 mm;
wherein the enteric membrane begins to dissolve within a pH range of about 4.5 to about 6.5;
wherein the enteric membrane is present in an amount in a range of about 25% to about 35% by weight, based on the weight of the core particles; and
wherein the pharmaceutical dosage form, upon administration in a capsule to fasted healthy normal subjects at 600 mg free cysteamine base, provides:
(a) a mean Cmax upon oral dosing in a range of 2.3\xb10.6 mgL or in a range of 80% to 125% thereof; and
(b) a mean AUC (0-inf_D) upon oral dosing in a range of 0.84\xb10.19 min*mgLmg or in a range of 80% to 125% thereof.
2. The pharmaceutical composition of claim 1, wherein the particle sizes of the beads are in a range of about 0.7 mm to about 2.5 mm.
3. The pharmaceutical dosage form of claim 1, wherein the distribution of bead sizes is characterized by at least 80% by weight of the beads having a particle size in a range of about 850 \u03bcm to about 1180 \u03bcm.
4. The pharmaceutical composition of claim 1, wherein 5% or less of the beads by weight are retained on a #12 mesh (1.68 mm) screen and 10% or less by weight pass through a #20 mesh (0.84 mm) screen.
5. The pharmaceutical composition of claim 1, wherein the distribution of bead sizes is characterized by less than 5% by weight of the beads being retained on a 1400 \u03bcm sieve.
6. The pharmaceutical dosage form of claim 1, wherein the distribution of bead sizes is characterized by less than 30% by weight of the beads being retained on a 1180 \u03bcm sieve.
7. The pharmaceutical dosage form of claim 1, wherein the distribution of bead sizes is characterized by less than 70% by weight of the beads being retained on a 1000 \u03bcm sieve.
8. The pharmaceutical dosage form of claim 1, wherein the distribution of bead sizes is characterized by less than 20% by weight of the beads being retained on a 850 \u03bcm sieve.
9. The pharmaceutical dosage form of claim 1, wherein the distribution of bead sizes is characterized by at least 15% by weight of the beads being retained on a 1180 \u03bcm sieve.
10. The pharmaceutical dosage form of claim 1, wherein the distribution of bead sizes is characterized by at least 50% by weight of the beads being retained on a 1000 \u03bcm sieve.
11. The pharmaceutical dosage form of claim 1, wherein the distribution of bead sizes is characterized by at least 10% by weight of the beads being retained on a 850 \u03bcm sieve.
12. The pharmaceutical dosage form of claim 1, wherein the distribution of bead sizes is characterized by a median particle size in a range of about 850 \u03bcm to about 1180 \u03bcm.
13. The pharmaceutical dosage form of claim 1, wherein the bead core particle further comprises a filler.
14. The pharmaceutical dosage form of claim 1, wherein the cysteamine (as free base) is present in the bead core particle in an amount of at least 10 wt. %.
15. The pharmaceutical dosage form of claim 1, wherein the cysteamine or pharmaceutically acceptable salt thereof is a pharmaceutically acceptable salt of cysteamine.
16. The pharmaceutical dosage form of claim 1, wherein 5% or less of the bead core particles by weight are retained on a #12 mesh (1.68 mm) screen and 10% or less by weight pass through a #20 mesh (0.84 mm) screen.
17. The pharmaceutical dosage form of claim 1, wherein the enteric-coated beads are characterized by acid resistance such that not more than 10% of the cysteamine in the beads is dissolved after a period of two hours in a 0.1N HCl solution.
18. The pharmaceutical dosage form of claim 1, wherein the enteric-coated beads are characterized by dissolution such that 80% of the cysteamine or pharmaceutically acceptable salt thereof is released within 20 minutes in a solution buffered at pH 6.8.
19. The pharmaceutical dosage form of claim 1, further comprising a capsule shell enclosing the plurality of beads.
20. The pharmaceutical dosage form of claim 1, wherein the beads provide a mean Cmax and mean AUC (0-inf_D) upon oral dosing, fasted, when administered inside a capsule shell that are bioequivalent to the mean Cmax and mean AUC (0-inf_D) upon oral dosing, fasted, when administered without a capsule shell.
21. The pharmaceutical dosage form of claim 1, wherein the enteric membrane comprises an enteric material that begins to dissolve at pH of about 5.5 in an aqueous solution.
22. The pharmaceutical dosage form of claim 1, wherein the pharmaceutical dosage form, upon administration in a capsule to fasted healthy normal subjects at 600 mg free cysteamine base, provides:
(a) a mean Cmax upon oral dosing in a range of 2.3\xb10.6 mgL; and
(b) a mean AUC (0-inf_D) upon oral dosing in a range of 0.84\xb10.19 min*mgLmg.
23. The pharmaceutical dosage form of claim 1, wherein the pharmaceutical dosage form, upon administration in a capsule to fasted healthy normal subjects at 600 mg free cysteamine base, provides:
(a) a mean Cmax upon oral dosing of 2.3 mgL or in a range of 80% to 125% thereof; and
(b) a mean AUC (0-inf_D) upon oral dosing of 0.84 min*mgLmg or in a range of 80% to 125% thereof.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A key for unlocking a toner hopper of an image forming apparatus, comprising:
a first member;
at least one first projection attached to said first member, said first projection configured to unlock a first locking-type toner hopper of an image forming apparatus; and
at least one second projection attached to the first member, the second projection configured to unlock a second locking-type toner hopper,
wherein said key is not formed monolithically with a toner container.
2. The key according to claim 1, wherein said at least one first projection includes at least two first projections configured to be received by, and unlock a lock of the first toner hopper.
3. The key according to claim 2, wherein said at least two first projections have a first spacing, and wherein said at least two first projections are substantially rectangular, and have a width sufficient to allow said at least two first projections to be received by two slots included on the lock of the first hopper.
4. A key for unlocking a toner hopper of an image forming apparatus, comprising:
a first member: and
at least one projection attached to said first member, said projection configured to unlock a locking-type toner hopper of an image forming apparatus;
wherein said key is not formed monolithically with a toner container,
wherein said at least one projection includes at least two first projections configured to be received by, and unlock a lock of a toner hopper of an image forming apparatus, and
wherein said at least two projections have a first spacing, and wherein said key further comprises at least two second projections having a second spacing, said second spacing larger than said first spacing.
5. The key according to claim 4, further comprising a first indicia corresponding to said first at least two projections; and
a second indicia corresponding to said at least two second projections.
6. The key according to claim 4, wherein said at least two first projections are provided on an opposite side of said first member from said at least two second projections.
7. A key for unlocking a toner hopper of an image forming apparatus, comprising:
a first member, and
at least one projection attached to said first member, said projection configured to unlock a locking-type toner hopper of an image forming apparatus;
wherein said key is not formed monolithically with a toner container, and
wherein said key includes a plurality of projections arranged to be received by and unlock, at least two different locking-type toner hoppers.
8. A toner refill kit for refilling a locking hopper of an image forming apparatus, said kit comprising the combination of:
a first container containing toner; and
a key having at least one projection configured to be received by and unlock a lock of a toner hopper of an image forming apparatus;
wherein said key is not monolithically formed with said first container.
9. A toner refill kit for refilling a locking hopper of an image forming apparatus, said kit comprising the combination of:
a first container containing toner;
a key having at least one projection configured to be received by and unlock a lock of a toner hopper of an image forming apparatus; and
a second container configured to store said key, said second container configured to engage with said first container;
wherein said key is not monolithically formed with said first container.
10. The kit according to claim 8, wherein said at least one projection of said key comprises at least two projections configured to be received by a lock of a locking-type toner hopper of an image forming apparatus.
11. A key for unlocking a toner hopper of an image forming apparatus, comprising:
a body member;
means for unlocking a first locking-type toner hopper of an image forming apparatus, the means for unlocking a first hopper disposed on the body member; and
means for unlocking a second locking-type toner hopper, the means for unlocking a second hopper disposed on the body member.
12. The key according to claim 11, wherein the key is separate from a toner container.
13. The key according to claim 11, wherein the key is not configured to container toner.
14. The key according to claim 11, wherein the means for unlocking a first hopper and the means for unlocking a second hopper extend from the body member in directions different from one another.
15. The key according to claim 11, wherein the means for unlocking a first hopper comprise at least one first projection.
16. The key according to claim 11, wherein the means for unlocking a first hopper comprises at least two first projections and the means for unlocking a second hopper comprises at least two second projections.
17. The key according to claim 16, wherein a distance between the at least two first projections is larger than a distance between the at least two second projections.
18. The toner refill kit according to claim 8, wherein the key comprises a protrusion configured to be received by and unlock a lock of another toner hopper.
19. The toner refill kit according to claim 18, wherein the projection comprises at least two projections, and the protrusion comprises at least two protrusions.
20. The toner refill kit according to claim 19, wherein a distance between the at least two projections is greater than a distance between the at least two protrusions.